Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Mili Gu"'
Autor:
Jaspreet Kaur, Vishakha Grover, Jyoti Gupta, Mili Gupta, Vinay Kapur, Manjula Mehta, Deborah M Lyle, Tanvi Samujh, Ashish Jain
Publikováno v:
Journal of Indian Society of Periodontology, Vol 27, Iss 5, Pp 515-523 (2023)
Background: There is a bidirectional link between diabetes and periodontal disease. Control of active periodontal infection is an essential requisite to maintain optimal oral and systemic health in diabetic patients. The purpose of this study was to
Externí odkaz:
https://doaj.org/article/b5220b9a10cf4be9a9cb435b48ac957a
Autor:
Terry Patamawenu, Hang Lu, Diane Sweeny, June-Home Chen, Mili Gu, Jason Catania, Stefanie Kluepfel-Stahl, David G. Alleva, Janet L. Lathey, Jacob Minang, Kavita Sapru, Katalin Baranji, Zenbework Fesseha, Alan Ng, Hannah Sanford, Jie Feng
Publikováno v:
Clinical and Vaccine Immunology. 20:986-997
The cell-based anthrax toxin neutralization assay (TNA) is used to determine functional antibody titers of sera from animals and humans immunized with anthrax vaccines. The anthrax lethal toxin is a critical reagent of the TNA composed of protective
Autor:
Xiaomi Tong, Huei-Hsiung Yang, John K. Brehm, Heidi Agostini, Clifford C. Shone, Yanfang Chu, Virginia Johnson, Joanna McGlashan, Joanna Clancy, Mili Gu, Makie Taal
Publikováno v:
Infection and Immunity. 77:2795-2801
The clostridial neurotoxins include tetanus toxin and the seven antigenically different botulinum neurotoxins (BoNTs), all of which exert their action by blocking the calcium-mediated release of neurotransmitters (24). The BoNTs act principally on th
Publikováno v:
Vaccine. 25:526-534
The inclusion of an adjuvant, in addition to the existing aluminum hydroxide, in the formulation of the licensed anthrax vaccine BioThrax may have the potential to positively modify immune responses. Some potential desirable outcomes from the inclusi
Autor:
Jeffrey Carrell, Mili Gu, Wendy Halpern, Ernest Boyd, Krzysztof J. Grzegorzewski, Angela Mahoney, Heidi Agostini, David Stolow, Jonathan Hirsch, Todd A. Riccobene, Kevin P. Baker
Publikováno v:
Pharmaceutical Research. 19:1720-1729
Purpose. AlbugraninTM fusion protein is recombinant granulocyte colony stimulating factor (rG-CSF) genetically fused at its N-terminus to the C-terminus of recombinant serum human albumin and is expected to have a relatively long half-life compared w
Publikováno v:
Journal of Clinical Investigation. 101:2615-2621
Transforming growth factor beta is a potent immunomodulator with both pro- and antiinflammatory activities. Based on its immunosuppressive actions, exogenous TGF-beta has been shown to inhibit autoimmune and chronic inflammatory diseases. To further
Autor:
Shipra Gupta, Sunil Dogra, Gurparkash Singh Chahal, Savita Prashar, Angadveer Pal Singh, Mili Gupta
Publikováno v:
Indian Dermatology Online Journal, Vol 12, Iss 2, Pp 281-284 (2021)
Objectives: Psoriasis is a common, chronic, non-communicable skin disease with no clear etiology or cure. Periodontitis is a chronic inflammatory condition which is now known to significantly influence various systemic diseases as an established risk
Externí odkaz:
https://doaj.org/article/b8ecfcfa9c2e407397bb1390f0a4fa70
Publikováno v:
FEBS Letters. 365:95-97
The envelope glycoproteins of HIV are required for viral infectivity. Proteolysis of the precursor envelope glycoprotein gp160 results in the formation of gp120 and gp41. Cleavage occurs after the sequence ArgGluLysArg. This sequence is expe
Autor:
Dennis M. Klinman, Mitsuhiro Takeno, Motohide Ichino, Mili Gu, Galina Yamshchikov, Gil Mor, Jacqueline Conover
Publikováno v:
Gene Vaccination: Theory and Practice ISBN: 9783642468698
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6722ccde77dddd7efecfb4129d52c4a3
https://doi.org/10.1007/978-3-642-46867-4_14
https://doi.org/10.1007/978-3-642-46867-4_14
Autor:
Mitsuhiro Takeno, Dennis M. Klinman, Galina Yamshchikov, Jacqueline Conover, Mili Gu, Gil Mor, Motohide Ichino
Publikováno v:
Springer seminars in immunopathology. 19(2)
DNA technology has been harnessed to produce a variety of plasmid-based vaccines designed to prevent viral, bacterial and parasitic infections. The rapid adoption and implementation of this novel vaccine strategy carries with it important safety and